ProBioGen and Evotec Technologies Announce Successful Completion of Collaboration on Automated Cell Selection Technology


ProBioGen AG and Evotec Technologies GmbH have announced the successful completion of their collaboration - the joint evaluation of methods and instrumentation for the selection of high producer cells. ProBioGen could show based on it's cell-based assay technology, know how and expertise in cGMP cell culture that Evotec's Cytocon(TM) device can be employed for the selection of high producer cell lines used in pharmaceutical development and manufacturing applications.

Both companies emphasize their great satisfaction with the mutually inspiring and successful cooperation, and scientists from both companies professed their interest in future common projects.

Other news from the department business & finance

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics